The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 219.00
Bid: 218.00
Ask: 219.00
Change: 5.00 (2.34%)
Spread: 1.00 (0.459%)
Open: 214.00
High: 224.50
Low: 214.00
Prev. Close: 214.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact

Fri, 23rd Dec 2022 18:15

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Fiinu PLC - Surrey, England-based fintech company - Says information and insights company TransUnion is supporting Fiinu Bank's overdraft solution platform through TransUnion's open banking offering and credit reference data. "This information will provide an in-depth understanding of a consumer's financial situation and help Fiinu, which is a registered bank, to deliver robust open banking-driven eligibility checks of consumers applying for an overdraft," Fiinu adds.

----------

GRC International Group PLC - Ely, England-based provider of products and services for IT governance, risk management and compliance - Says IT governance wins G-Cloud 13 framework contract. Will provide more than 100 of its products and services through UK government's digital marketplace. "This eliminates the need for its customers to go through a full tender process," GRC adds. "Launched in 2012, G-Cloud 13 is an online catalogue and the newest iteration of the G-Cloud framework, which is used by the UK public sector to identify and acquire a diverse range of cloud-based computing services."

----------

Eco Atlantic Oil & Gas Ltd - Toronto-based oil and gas exploration company - Receives approval from South Africa's Department of Mineral Resources & Energy and Petroleum Agency of South Africa for acquisition of additional interest in Block 3B/4B. Now holds interest of just over 26%.

----------

Corre Energy BV - Groningen, Netherlands-based renewable energy storage solutions and green hydrogen producer - Signs binding commercial terms for a 15-year offtake agreement with renewable power supplier Eneco. Deal concerns entire storage capacity of the Zuidwending compressed air energy storage in Netherlands. "Under the terms of the arrangement, Corre Energy will construct, operate and maintain the facility and Eneco will optimise the entire output of the storage site on behalf of Corre Energy. Eneco will provide market access services, enabling Corre Energy to benefit from revenue linked to the high flexibility value of the asset, while also guaranteeing a base level of income," Corre adds.

----------

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Agrees put option to sell 5% interest in AZD 1656 asset, which treats inflammatory pulmonary and cardiovascular disease. Also sells royalty sharing agreement with St George Street Capital. Both sold to Conduit Pharmaceuticals Ltd for GBP3.3 million, to be satisfied in shares. In addition, Cizzle raises GBP115,586 through subscription of 7.4 million new shares at 1.6 pence each.

----------

Kropz PLC - African phosphate developer - Says in process of engaging with possible successor to Mark Summers as chief executive officer. "The formal appointment and announcement are expected to be finalised in early January 2023. In the meantime, Mark Summers has agreed to remain as CEO until the appointment is formalised," Kropz adds. Summers, and outgoing operating chief Michelle Lawrence, are staying with Kropz under short-term consulting agreements. Kropz adds: "Progress is being made with regards to the first bulk concentrate sale from Kropz Elandsfontein. The sale of approximately 30,000 tonnes of concentrate is expected to ship in early 2023. The product, which has been generated throughout the commissioning and ramp up period, will be sold at a discount to current market prices."

----------

Star Phoenix Group Ltd - oil and gas company focused on Trinidad and Indonesia - Will be unable to appoints its new auditor or publish its results for the year ended June 30 by the end of 2022, as resolutions at its general meeting on Monday are rejected by shareholders. Shareholders vote for the removal of the auditor and against the appointment of a new auditor. As a result, the oilfield services company's share will be suspended from trading on AIM from the morning of January 3.

----------

abrdn China Investment Co Ltd - Invests predominantly in Chinese equities - Gets regulatory approval for qualified foreign investor licence. Allows it "access to a broader investible universe within Chinese equities".

----------

Triple Point Social Housing REIT PLC - London-based real estate investment trust - Notes Regulator of Social Housing takes enforcement action against My Space Housing Solutions, or My Space. My Space ratings downgraded to V4 for viability and G4 for governance, from V3 and G3, respectively. Triple Point Social Housing has 34 properties leased to My Space, representing 7.5% of contracted rent roll. Triple Point adds: "The group's investment manager, Triple Point Investment Management LLP, continues to engage actively with My Space regarding improvements to its operations, with the aim of increasing rental payments and agreeing a payment schedule in respect of rent arrears. The manager also notes that My Space has sought to address a number of the concerns noted in today's regulatory judgement. However, as part of the ongoing engagement with My Space, the group will consider whether it is appropriate to put in place alternative arrangements for some or all of its properties."

----------

PureTech Health PLC - Boston, US-based biotherapeutics company - Says trial results find LYT-300 achieves blood levels of allopregnanolone "at or above those associated with therapeutic benefit". Chief Medical Officer Julie Krop adds: "Today's results make us very excited about the potential of LYT-300 to unlock the full therapeutic benefit of allopregnanolone, which to date has been limited to a small subset of patients."

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
25 Apr 2024 10:07

Puretech Health operating losses narrow in 'landmark year'

(Sharecast News) - Biotechnology company Puretech Health said on Thursday that 2023 had been "a landmark year" for the group, making "strong strategic and clinical progress".

Read more
25 Apr 2024 09:59

PureTech touts "momentum" as grants shrivel but annual loss narrows

(Alliance News) - PureTech Health PLC on Thursday maintained an optimistic outlook for the year ahead, despite seeing annual revenue fall.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 21:57

EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
11 Apr 2024 13:01

US FDA hands fast track to PureTech head and neck cancer treatment

(Alliance News) - PureTech Health PLC on Thursday said that its LYT-200 cancer treatment has received a significant endorsement from the US drugs regulator.

Read more
9 Apr 2024 11:33

PureTech Health CEO Zohar moves to head-up portfolio firm Seaport

(Alliance News) - PureTech Health PLC on Tuesday said its founding chief executive officer, Daphne Zohar, will shift to become CEO of Seaport Therapeutics, a biopharmaceutical company founded by PureTech.

Read more
9 Apr 2024 07:48

PureTech founder steps down as CEO to lead SeaPort spin-off

(Sharecast News) - Clinical-stage biotherapeutics group PureTech has announced that its founding chief executive is to step down to lead SeaPort Therapeutics, a PureTech company she founded that has just raised $100m in Series A financing.

Read more
19 Mar 2024 16:57

LONDON MARKET CLOSE: European large-caps rise on eve of Fed decision

(Alliance News) - Blue-chip stock prices in Europe closed higher on Tuesday, showing little signs of nerves ahead of Wednesday's Federal Reserve decision and UK inflation reading.

Read more
19 Mar 2024 11:16

PureTech shares jump on USD100 million tender offer proposal

(Alliance News) - PureTech Health PLC on Tuesday said it plans to return USD100 million to shareholders with a tender offer, starting after it publishes its annual report in April.

Read more
19 Mar 2024 09:46

Puretech Health proposes $100m capital return

(Sharecast News) - Biotherapeutics company PureTech Health has proposed a capital return of $100.0m to its shareholders by way of a tender offer.

Read more
13 Mar 2024 12:27

PureTech Health celebrates drug designation for LYT-200 from US FDA

(Alliance News) - PureTech Health PLC on Wednesday touted the efficacy of its acute myeloid leukaemia therapy, after securing a regulatory designation from the US Food & Drug Administration.

Read more
27 Feb 2024 11:28

PureTech notes positive results from Shionogi's EndeavorRx ADHD trial

(Alliance News) - PureTech Health PLC on Tuesday noted that its founded entity, Akili Inc, has announced positive results from a phase 3 clinical trial of EndeavorRx for children with attention deficit hyperactivity disorder in Japan.

Read more
20 Dec 2023 09:53

PureTech makes strong progress, expects "multiple catalysts" next year

(Alliance News) - PureTech Health PLC on Wednesday said it made "strong strategic and clinical progress" in 2023, and predicted "a productive and exciting" tear to come.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.